CompletedPhase 2NCT01468454
Phase II Safety and Efficacy Study of 18FDOPA PET-CT in Children With Hyperinsulinemic Hypoglycemia
Studying Congenital isolated hyperinsulinism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Hospital of Philadelphia
- Principal Investigator
- Lisa J States, MDChildren's Hospital of Philadelphia
- Intervention
- 18 F-DOPA(drug)
- Enrollment
- 130 enrolled
- Eligibility
- All sexes
- Timeline
- 2009 – 2018
Study locations (1)
- The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Collaborators
University of Pennsylvania
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01468454 on ClinicalTrials.gov